1,445 results on '"Wildiers, Hans"'
Search Results
2. Serum methylmalonic acid concentrations at breast cancer diagnosis significantly correlate with clinical frailty
3. How to incorporate chronic health conditions in oncologic decision-making and care for older patients with cancer? A survey among healthcare professionals
4. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.
5. Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium
6. Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium
7. Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer
8. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
9. Obesity-associated changes in molecular biology of primary breast cancer
10. Limited impact of adding digital breast tomosynthesis to full field digital mammography in an elevated breast cancer risk population
11. Outcomes in studies regarding older patients with prostate cancer: A systematic review
12. Study protocol for two stepped-wedge interventional trials evaluating the effects of holistic information technology-based patient-oriented management in older multimorbid patients with cancer: The GERONTE trials
13. Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): Final overall survival results from a randomized phase 3 trial
14. Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study
15. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling
16. Self-reported electronic symptom monitoring in older patients with multimorbidity treated for cancer: Development of a core dataset based on expert consensus, literature review, and quality of life questionnaires
17. Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative
18. Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast CancerBiomarker Analysis of the Phase III NALA Study in HER2+ MBC
19. Reporting on patient’s body mass index (BMI) in recent clinical trials for patients with breast cancer: a systematic review
20. Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program
21. Reporting on invasive lobular breast cancer in clinical trials: a systematic review
22. Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab
23. Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer
24. Challenges of caring for older patients with multimorbidity including cancer
25. Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06).
26. Efficacy and genomic analysis of HER2-mutant, metastatic triple-negative breast cancer treated with neratinib alone or in combination with trastuzumab in the phase 2 SUMMIT basket trial.
27. Abstract 18324: Artificial Intelligence ECG as a Novel Method to Detect Cardiotoxicity After Anthracyclines
28. Long-term health-care utilisation in older patients with cancer and the association with the Geriatric 8 screening tool: a retrospective analysis using linked clinical and population-based data in Belgium
29. Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
30. The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study
31. Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1
32. Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1.
33. Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
34. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
35. Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes
36. Oncological care organisation during COVID-19 outbreak.
37. Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study
38. Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer
39. Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology
40. Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast
41. Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study
42. Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer
43. Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study
44. Elevated CA 15.3 in Newly Diagnosed Breast Cancer: A Retrospective Study
45. Geriatric assessment in the management of older patients with cancer – A systematic review (update)
46. Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial
47. Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer
48. Clinical Trial Design for Older Cancer Patients
49. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
50. Correction: Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.